| |
 Search
 Advanced
 Tutorial
 Results
 Saved Refs ( 0)
 About

Tutorial Introduction This tutorial with help you learn what makes Twease different and how Twease can help you find what you are looking for, fast. Twease is a web-based tool to search Medline® abstracts. Twease indexes each word of Medline® and provides features that can transparently expand your search to help find the information you are looking for. Twease searches are also partially case sensitive. Short terms are case sensitive, while longer terms are not. For instance, TnT is different from TNT (TnT often stands for Troponin T while TNT often stands for trinitrotoluene). For more details on Twease's case sensitivity, see the Case Sensitive Searches tutorial page. Finally, Twease can automatically discover common abbreviations for search phrases (e.g., "protein kinase C" will discover PKC, PK-C, aPKC, etc.) and rewrite queries to use these abbreviations. This feature is available through the Slider (on the top right) and the Advanced pane. To learn more about searching Twease, visit the rest of this tutorial.
 |
|
Twease
helps you find precisely what you're looking for,
quickly. Search
Medline®
abstracts
in new ways and find the information you need. Type your search
phrase here and click "Search" to get started,
or, take a tour of
Twease
with our Tutorial.
|
|
You have no saved references. Click within Query Results to save references.
Open the Saved Refs pane to view / export your saved references.
|
 |
|
Query Stats
|
|
doclookup-time
|
377
|
|
queue-time
|
0
|
|
exec-time
|
140
|
|
total-exec-time
|
517
|
|
Last Executed Query:
pmid-list:17407089,16476820,12908108,16143870,15248095,15667412,16276409,12960222,15891913,16339213,12499504,16815977,16476945,12124993,11039577,11685207,17868079,10699187,11843700,11309678,15197701,12676568,14732620,11723204,17598599,11809724,14974310,18306668,17690846,16684598,18190593,11470961,17100993,14607301,15537668,17122756,12778437,15210521,11015453,18202664,12163196,17594340,17598600,12925368,15079007,16009377,12161613,11087788,12736085,16009769,16102895,17035675,12552568,17427918,17560499,11402104,17348041,16826525,16055926,17531954,15596607,12023066,16788734,10610178,11266693,16602018,12202986,16682546,12134148,12432827,17098887,16832076,15517445,18305248,12490534,15637712,15164410,12876245,16026783,11377972,15356686,10891911,15210518,12743246
|

|
Query Results 1 - 20 of 84
|
Queue time:
Execution time:
|
0ms
140ms
|
| |
|
Related Terms:
|
spastic[84], hereditary[83], the[81], in[83], a[80], and[80], of[82]
|
|
|
<<
<
1
2
3
4
5
>
>>
|
PMID
|
Text
|
17407089
|
Clinical characteristics and spastin gene mutation analysis on an autosomal dominant kindred with hereditary spastic paraplegia objective : To investigate … (2007 Apr)
clinical characteristics and spastin gene mutation analysis on an autosomal dominant kindred with hereditary spastic paraplegia objective : To investigate the clinical characteristics and analyze spastin gene mutation on a kindred with hereditary spastic paraplegia ( HSP ) . methods : All family members were studied through clinical examinations . The proband and another two patients in this kindred were subjected to electromyography ( EMG ) examinations . The proband was subjected to thoracic MRI examination too . mutation analysis of spastin gene was screened by polymerase chain reaction combined with DNA sequencing in the proband and his father . results : All patients in the kindred manifested as classical HSP . thoracic MRI revealed atrophies of the spinal cord in the proband . No abnormal spastin gene mutation was detected in these two patients . conclusion : This kindred has typical clinical manifestations of HSP . The pathogenesis has no association with mutation of the exons of spastin gene .
|
16476820
|
A missense mutation in the coiled coil domain of the kif5a gene and late onset hereditary spastic paraplegia. (2006 Feb)
A missense mutation in the coiled coil domain of the kif5a gene and late onset hereditary spastic paraplegia . background : To our knowledge , up to now , only 2 mutations in the kif5a gene , a member of the kinesin superfamily , have been identified as the molecular cause of early onset autosomal dominant hereditary spastic paraparesis ( adhsp ) . objective : To assess the genetic defect in a family with late onset adhsp . patients AND methods : Only the proband agreed to undergo complete neurological testing and mutational analysis . The proband was screened for mutations in the spastin , atlastin , nipa1 , and kif5a genes , either by denaturing high performance liquid chromatography or sequence analysis . results : The history of the family was consistent with adhsp characterized by late onset of the disease . mutational analysis results were negative for the spastin , atlastin , and nipa1 genes but identified a missense mutation ( c . 1082c T ) in the coiled coil coding region of the kif5a gene . conclusions : This finding enlarges the phenotypic spectrum of adhsp linked to kif5a and enhances the role of that gene in the epidemiology of this disease . We propose that the kif5a gene should be routinely analyzed in patients with hereditary spastic paraplegia negative for spastin and atlastin mutations .
|
12908108
|
Identification of the drosophila melanogaster homolog of the human spastin gene. (2003 Aug)
identification of the drosophila melanogaster homolog of the human spastin gene . The human SPG4 locus encodes the spastin gene , which is responsible for the most prevalent form of autosomal dominant hereditary spastic paraplegia ( AD HSP ) , a neurodegenerative disorder . Here we identify the predicted gene product cg5977 as the drosophila homolog of the human spastin gene , with much higher sequence similarities than any other related AAA domain protein in the fly . furthermore we report a new potential transmembrane domain in the N terminus of the two homologous proteins . during embryogenesis , the expression pattern of drosophila spastin becomes restricted primarily to the central nervous system , in contrast to the ubiquitous expression of the vertebrate spastin genes . given this nervous system specific expression , it will be important to determine if drosophila spastin loss of function mutations also lead to neurodegeneration .
|
16143870
|
Spinal cord magnetic resonance imaging in autosomal dominant hereditary spastic paraplegia. (2005 Oct)
spinal cord magnetic resonance imaging in autosomal dominant hereditary spastic paraplegia . hereditary spastic paraplegia ( HSP ) is a genetically heterogeneous group of neurodegenerative disorders characterized by progressive lower extremity weakness and spasticity . HSP pathology involves axonal degeneration that is most pronounced in the terminal segments of the longest descending ( pyramidal ) and ascending ( dorsal columns ) tracts . In this study , we compared spinal cord magnetic resonance imaging ( MRI ) in 13 HSP patients with four different types of autosomal dominant hereditary spastic paraplegia ( spg3a , SPG4 , SPG6 , and SPG8 ) with age matched control subjects . The cross section area of HSP subjects at cervical level C2 was 59 . 42 / 12 . 57 mm2 and at thoracic level T9 was 28 . 58 / 5 . 25 mm2 . Both of these values were less than in the healthy controls ( p 0 . 001 ) . The degree of cord atrophy was more prominent in patients with SPG6 and SPG8 who had signs of severe cord atrophy ( 47 . 60 / 6 . 58 mm2 at C2 , 21 . 40 / 2 . 4 mm2 at T9 ) than in subjects with SPG3 and SPG4 ( 66 . 0 / 8 . 94 mm2 at C2 , p 0 . 02 ; 31 . 75 / 2 . 76 mm2 at T9 , p 0 . 001 ) . these observations indicate that spinal …
|
15248095
|
Intragenic modifiers of hereditary spastic paraplegia due to spastin gene mutations. (2004 Oct)
intragenic modifiers of hereditary spastic paraplegia due to spastin gene mutations . hereditary spastic paraplegia ( HSP ) is a genetically heterogeneous neurodegenerative disease characterized by wide variability in phenotypic expression , both within and among families . The most common cause of autosomal dominant HSP is mutation of the gene encoding spastin , a protein of uncertain function . We report the existence of intragenic polymorphisms of spastin that modify the HSP phenotype . One ( S44L ) is a previously described recessively acting allele and the second is a novel allele affecting the adjacent amino acid residue ( P45Q ) . In 4 HSP families in which either L44 or Q45 segregates independently of a missense or splicing mutation in the AAA domain of spastin , L44 and Q45 are each associated with a striking decrease in age at onset in the presence of the AAA domain mutations . using a bioinformatics approach , we found that the highly conserved S44 is predicted to be phosphorylated by a number of family members of the proline directed serine / threonine cyclin dependent kinases ( Cdks ) . Cdk1 and Cdk5 showed no kinase activity toward synthetic spastin peptide in an in vitro kinase assay , suggesting that this serine residue may be phosphorylated by a different Cdk . Our identification of S44L and P45Q as modifiers of the HSP phenotype suggests a role for spastin phosphorylation by Cdks in the neurodegeneration of the most common form of HSP .
|
15667412
|
Hereditary spastic paraplegia with cerebellar ataxia : a complex phenotype associated with a new SPG4 gene mutation. (2005 Jan)
hereditary spastic paraplegia with cerebellar ataxia : a complex phenotype associated with a new SPG4 gene mutation . complex forms of hereditary spastic paraplegia ( HSP ) are rare and usually transmitted in an autosomal recessive pattern . A family of four generations with autosomal dominant hereditary spastic paraplegia ( AD HSP ) and a complex phenotype with variably expressed co existing ataxia , dysarthria , unipolar depression , epilepsy , migraine , and cognitive impairment was investigated . genetic linkage analysis and sequencing of the SPG4 gene was performed and electrophysiologic investigations were carried out in six individuals and positron emission tomography ( PET ) in one patient . The disease was linked to the SPG4 locus on chromosome 2p as previously reported for pure HSP . sequence analysis of the SPG4 ( spastin ) gene identified a novel 1593 C T ( gln490stop ) mutation leading to premature termination of exon 12 with ensuing truncation of the encoded protein . however , the mutation was only identified in those individuals who were clinically affected by a complex phenotype consisting of HSP and cerebellar ataxia . other features noted in this kindred including epilepsy , cognitive impairment , depression , and migraine did not segregate with the HSP phenotype or mutation , and therefore the significance of these features to SPG4 is unclear . electrophysiologic investigation showed increased central conduction time at somatosensory evoked potentials measured from the lower limbs as the only abnormal finding in two affected individuals …
|
16276409
|
All neuropathies great and small. (2005 Nov)
All neuropathies great and small . autosomal dominant pure hereditary spastic paraplegia ( AD HSP ) is characterized by the degeneration of long axons in corticospinal tracts and dorsal columns , resulting in spasticity and difficulty walking . mutations in the SPG4 gene product spastin are the predominant genetic lesions associated with this inherited disease . In this issue , Orso et al . examine and reconcile existing drosophila mutants of spastin and generate a new model for HSP by overexpression of a fly spastin transgene that carries a mutation prevalent in human AD HSP ( see the related article beginning on page 3026 ) . expression of this mutant spastin protein produces pathology in flies reminiscent of the human disease , including adult locomotion defects , in addition to causing aberrant synaptic morphology and altered microtubule stability . Both movement and synaptic defects in fly mutants were ameliorated by treatment with the microtubule modifying agent vinblastine . The results are consistent with disease causing mutations in human spastin producing dominant negative proteins and confirm the usefulness of drosophila genetic techniques to understand HSP and other neurodegenerative diseases .
|
12960222
|
Meta analysis of age at onset in spastin associated hereditary spastic paraplegia provides no evidence for a correlation with mutational … (2003 Sep)
Meta analysis of age at onset in spastin associated hereditary spastic paraplegia provides no evidence for a correlation with mutational class .
|
15891913
|
Subcellular localization of spastin : implications for the pathogenesis of hereditary spastic paraplegia. (2005 Oct)
subcellular localization of spastin : implications for the pathogenesis of hereditary spastic paraplegia . hereditary spastic paraplegia ( HSP ) is a group of clinically and genetically heterogeneous diseases characterized by neuronal degeneration that is maximal at the distal ends of the longest axons of the central nervous system . The most common cause of autosomal dominant HSP is mutation of a novel gene encoding spastin , a protein whose function is still being elucidated . One clue concerning spastin function is its intracellular localization . Here , we describe a novel anti spastin antiserum designed to a unique epitope contained within all splicing isoforms . The antiserum exhibits specific immunostaining of recombinant spastin in intact , fixed cells . using this reagent , we find that endogenous spastin is located at the centrosome in a variety of cell types at all points in the cell cycle . This localization is resistant to microtubule disruption , suggesting that spastin may be an integral centrosomal protein . In addition to the centrosome , spastin also localizes at discrete focal regions along the axons of primary cultured neurons . these data lend additional support to the emerging hypothesis that spastin plays a role in microtubule dynamics , with a crucial role in microtubule organization .
|
16339213
|
Spastin and atlastin , two proteins mutated in autosomal dominant hereditary spastic paraplegia , are binding partners. (2006 Jan)
spastin and atlastin , two proteins mutated in autosomal dominant hereditary spastic paraplegia , are binding partners . The pure hereditary spastic paraplegias ( HSPs ) are a group of conditions in which there is a progressive length dependent degeneration of the distal ends of the corticospinal tract axons , resulting in spastic paralysis of the legs . Pure HSPs are most frequently inherited in an autosomal dominant pattern and are commonly caused by mutations either in the SPG4 gene spastin or in the spg3a gene atlastin . To identify binding partners for spastin , we carried out a yeast two hybrid screen on a brain cDNA library , using spastin as bait . remarkably , nearly all of the positive interacting prey clones coded for atlastin . We have verified the physiological relevance of this interaction using co immunoprecipitation , glutathione S transferase pull down and intracellular co localization experiments . We show that the spastin domain required for binding to atlastin lies within the N terminal 80 residues of the protein , a region that is only present in the predominantly cytoplasmic , full length spastin isoform . these data suggest that spastin and atlastin function in the same biochemical pathway and that it is the cytoplasmic function of spastin which is important for the pathogenesis of HSP . They also provide further evidence for a physiological and pathological role of spastin in membrane dynamics .
|
12499504
|
Spg3a : An additional family carrying a new atlastin mutation. (2002 Dec)
spg3a : An additional family carrying a new atlastin mutation . The authors report on a novel frameshift mutation ( c . 1688insa ) in the spg3a gene resulting in premature translation termination of the gene product atlastin . these data add a new variant to the second disease gene in autosomal dominant hereditary spastic paraplegia ( adhsp ) and lend definitive support to its causative role . By combining direct testing of spast and spg3a , at least 50 of adhsp families can now receive appropriate genetic diagnosis .
|
16815977
|
Interaction of two hereditary spastic paraplegia gene products , spastin and atlastin , suggests a common pathway for axonal maintenance. (2006 Jul)
interaction of two hereditary spastic paraplegia gene products , spastin and atlastin , suggests a common pathway for axonal maintenance . hereditary spastic paraplegia ( HSP ) is a neurodegenerative disorder that is characterized by retrograde axonal degeneration that primarily affects long spinal neurons . The disease is clinically heterogeneous , and there are 20 genetic loci identified . Here , we show a physical interaction between spastin and atlastin , two autosomal dominant HSP gene products . spastin encodes a microtubule ( MT ) severing AAA atpase ( atpase associated with various activities ) , and atlastin encodes a golgi localized integral membrane protein gtpase . atlastin does not regulate the enzymatic activity of spastin . We also identified a clinical mutation in atlastin outside of the gtpase domain that prevents interaction with spastin in cells . therefore , we hypothesize that failure of appropriate interaction between these two HSP gene products may be pathogenetically relevant . these data indicate that at least a subset of HSP genes may define a cellular biological pathway that is important in axonal maintenance .
|
16476945
|
Unexpected pathogenic mechanism of a novel mutation in the coding sequence of SPG4 ( spastin ). (2006 Feb)
unexpected pathogenic mechanism of a novel mutation in the coding sequence of SPG4 ( spastin ) . The authors report a nucleotide substitution ( c . 1216a G ) in SPG4 ( spastin ) causing hereditary spastic paraplegia . This apparent missense mutation in the atpase domain confers aberrant , in frame splicing and results in destabilization of mutated transcript . mutated protein is deficient in microtubule severing activity but , unlike neighboring mutations , shows regular subcellular localization . The authors data point to haploinsufficiency rather than a dominant negative effect as the disease causing mechanism for this mutation .
|
12124993
|
Mutation analysis of the spastin gene ( SPG4 ) in patients in germany with autosomal dominant hereditary spastic paraplegia. (2002 Jul)
mutation analysis of the spastin gene ( SPG4 ) in patients in germany with autosomal dominant hereditary spastic paraplegia . hereditary spastic paraplegias ( HSP ) comprise a genetically and clinically heterogeneous group of neurodegenerative disorders characterized by progressive spasticity and hyperreflexia of the lower limbs . autosomal dominant hereditary spastic paraplegia 4 linked to chromosome 2p ( SPG4 ) is the most common form of autosomal dominant hereditary spastic paraplegia . It is caused by mutations in the SPG4 gene encoding spastin , a member of the AAA protein family of atpases . In this study the spastin gene of HSP patients from 161 apparently unrelated families in germany was analyzed . The authors identified mutations in 27 out of the 161 HSP families ; 23 of these mutations have not been described before and only one mutation was found in two families . among the detected mutations are 14 frameshift , four nonsense , and four missense mutations , one large deletion spanning several exons , as well as four mutations that affect splicing . Most of the novel mutations are located in the conserved AAA cassette encoding region of the spastin gene . The relative frequency of spastin gene mutations in an unselected group of german HSP patients is approximately 17 . frameshift mutations account for the majority of SPG4 mutations in this population . The proportion of splice mutations is considerably lower than reported elsewhere .
|
11039577
|
Hereditary spastic paraplegia caused by mutations in the SPG4 gene. (2001 Jan)
hereditary spastic paraplegia caused by mutations in the SPG4 gene . autosomal dominant hereditary spastic paraplegia ( AD HSP ) is a genetically heterogeneous neurodegenerative disorder characterised by progressive spasticity of the lower limbs . The SPG4 locus at 2p21 p22 accounts for 40 50 of all AD HSP families . The SPG4 gene was recently identified . It is ubiquitously expressed in adult and foetal tissues and encodes spastin , an atpase of the AAA family . We have now identified four novel SPG4 mutations in german AD HSP families , including one large family for which anticipation had been proposed . mutations include one frame shift and one missense mutation , both affecting the walker motif B . Two further mutations affect two donor splice sites in introns 12 and 16 , respectively . RT PCR analysis of both donor splice site mutations revealed exon skipping and reduced stability of aberrantly spliced SPG4 mRNA . All mutations are predicted to cause loss of functional protein . In conclusion , we confirm in german families that SPG4 mutations cause AD HSP . Our data suggest that SPG4 mutations exert their dominant effect not by gain of function but by haploinsufficiency . If a threshold level of spastin were critical for axonal preservation , such threshold dosage effects might explain the variable expressivity and incomplete penetrance of SPG4 linked AD HSP .
|
11685207
|
Mutations in a newly identified gtpase gene cause autosomal dominant hereditary spastic paraplegia. (2001 Nov)
mutations in a newly identified gtpase gene cause autosomal dominant hereditary spastic paraplegia . The hereditary spastic paraplegias ( HSPs ; strümpell lorrain syndrome , MIM number 18260 ) are a diverse class of disorders characterized by insidiously progressive lower extremity spastic weakness ( reviewed in refs . 1 3 ) . eight autosomal dominant HSP ( adhsp ) loci have been identified , the most frequent of which is that linked to the SPG4 locus on chromosome 2p22 ( found in approximately 42 ) , followed by that linked to the spg3a locus on chromosome 14q11 q21 ( in approximately 9 ) . Only SPG4 has been identified as a causative gene in adhsp . Its protein ( spastin ) is predicted to participate in the assembly or function of nuclear protein complexes . Here we report the identification of mutations in a newly identified gtpase gene , spg3a , in adhsp affected individuals .
|
17868079
|
Analysis and mapping of cacnb4 , chrna1 , kcnj3 , scn2a and SPG4 , physiological candidate genes for porcine congenital … (2007 Sep)
analysis and mapping of cacnb4 , chrna1 , kcnj3 , scn2a and SPG4 , physiological candidate genes for porcine congenital progressive ataxia and spastic paresis . The cause of porcine congenital progressive ataxia and spastic paresis ( CPA ) is unknown . This severe neuropathy manifests shortly after birth and is lethal . The disease is inherited as a single autosomal recessive allele , designated cpa . In a previous study , we demonstrated close linkage of cpa to microsatellite sw902 on porcine chromosome 3 ( SSC3 ) , which corresponds syntenically to human chromosome 2 . This latter chromosome contains ion channel genes ( Ca ( 2 ) , K ( ) and Na ( ) ) , a cholinergic receptor gene and the spastin ( SPG4 ) gene , which cause human epilepsy and ataxia when mutated . We mapped porcine cacnb4 , kcnj3 , scn2a and chrna1 to ssc15 and SPG4 to SSC3 with the INRA minnesota porcine radiation hybrid panel ( imprh ) and we sequenced the entire open reading frames of cacnb4 and SPG4 without finding any differences between healthy and affected piglets . An anti epileptic drug treatment with ethosuximide did not change the severity of the disease , and pigs with CPA did not exhibit the corticospinal tract axonal degeneration found in humans suffering from hereditary spastic paraplegia , which is associated with mutations in SPG4 . For all these reasons , the hypothesis that cacnb4 , chrna1 , kcnj3 , scn2a or …
|
10699187
|
Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia. (2000 Apr)
spectrum of SPG4 mutations in autosomal dominant spastic paraplegia . autosomal dominant hereditary spastic paraplegia ( AD HSP ) is a group of genetically heterogeneous neurodegenerative disorders characterized by pro gressive spasticity of the lower limbs . Five AD HSP loci have been mapped to chromosomes 14q , 2p , 15q , 8q and 12q . The SPG4 locus at 2p21 p22 has been shown to account for approximately 40 of all AD HSP families . SPG4 encoding spastin , a putative nuclear AAA protein , has recently been identified . Here , sequence analysis of the 17 exons of SPG4 in 87 unrelated AD HSP patients has resulted in the detection of 34 novel mutations . these SPG4 mutations are scattered along the coding region of the gene and include all types of DNA modification including missense ( 28 ) , nonsense ( 15 ) and splice site point ( 26 . 5 ) mutations as well as deletions ( 23 ) and insertions ( 7 . 5 ) . The clinical analysis of the 238 mutation carriers revealed a high proportion of both asymptomatic carriers ( 14 / 238 ) and patients unaware of symptoms ( 45 / 238 ) , and permitted the redefinition of this frequent form of AD HSP .
|
11843700
|
Spectrum of SPG4 mutations in a large collection of north american families with hereditary spastic paraplegia. (2002 Feb)
spectrum of SPG4 mutations in a large collection of north american families with hereditary spastic paraplegia . background : hereditary spastic paraplegia ( HSP ) is a neurodegenerative disease characterized by progressive spasticity and weakness of the lower limbs . The most common form of HSP is caused by mutations in the SPG4 gene , which codes for spastin , an adenosine triphosphatase with various cellular activities ( AAA ) protein family member . objective : To investigate a large collection of predominantly north american patients with HSP for mutations in the spastin encoding gene , SPG4 . methods : DNA from 76 unrelated affected individuals was studied for mutations by single stranded conformational polymorphism analysis and direct sequencing . Each new variant identified was then analyzed in 80 control subjects to determine whether the variant is a common polymorphism or a rare mutation . All DNA samples were amplified by polymerase chain reaction , followed by electrophoresis and autoradiography . results : We identified 8 novel mutations and 5 previously reported mutations in 15 affected individuals . The novel mutations are 4 missense , 1 nonsense , 1 frameshift , and 2 splice mutations . Two polymorphisms ( one in an affected individual ) were also identified . conclusions : Our collection of families with HSP is different on a genetic level from those previously described . The percentage of our families with a SPG4 mutation is 10 lower than the 40 estimate of families with autosomal dominant HSP …
|
11309678
|
Identification and expression analysis of spastin gene mutations in hereditary spastic paraplegia. (2001 Apr)
identification and expression analysis of spastin gene mutations in hereditary spastic paraplegia . Pure hereditary spastic paraplegia ( SPG ) type 4 is the most common form of autosomal dominant hereditary SPG , a neurodegenerative disease characterized primarily by hyperreflexia and progressive spasticity of the lower limbs . It is caused by mutations in the gene encoding spastin , a member of the AAA family of atpases . We have screened the spastin gene for mutations in 15 families consistent with linkage to the spastin gene locus , SPG4 , and have identified 11 mutations , 10 of which are novel . Five of the mutations identified are in noninvariant splice junction sequences . reverse transcription PCR analysis of mRNA from patients shows that each of these five mutations results in aberrant splicing . One mutation was found to be leaky , or partially penetrant ; that is , the mutant allele produced both mutant ( skipped exon ) and wild type ( full length ) transcripts . This phenomenon was reproduced in in vitro splicing experiments , with a minigene splicing vector construct only in the context of the endogenous splice junctions flanking the splice junctions of the skipped exon . In the absence of endogenous splice junctions , only mutant transcript was detected . The existence of at least one leaky mutation suggests that relatively small differences in the level of wild type spastin expression can have significant functional consequences . This may account , at least in …
|
|
<<
<
1
2
3
4
5
>
>>
|
|
| You have no saved references. |
|
|